Minretumomab Biosimilar uses the same protein sequences as the therapeutic antibody minretumomab.Minretumomab is a mouse monoclonal antibody that was designed for the treatment of cancers that express the TAG-72 antigen. This includes breast, colon, lung, and pancreatic cancers.A wide range of derivatives has been used in pharmaceutical research. Examples include chimeric and humanized minretumomab, as well as a fusion protein of a minretumomab single-chain variable fragment and the enzyme beta-lactamase.
Purity:
>95% Determined by SDS-PAGE
Target:
TAG-72
Application Dilute:
In Vivo Grade Recombinant Human IgG1 Kappa Isotype Control Antibody
Application Notes:
Cross-Reactivity: <1EU/mg (<0.001EU/µg)Determined by LAL gel clotting assay. ResearchArea: Cancer immunology
* VAT and and shipping costs not included. Errors and price changes excepted
